Four definitions of thyroid status

References

Back to main article on Page 1

Abdalla, S. M., & Bianco, A. C. (2014). Defending plasma T3 is a biological priority. Clinical Endocrinology, 81(5), 633–641. https://doi.org/10.1111/cen.12538

Beck-Peccoz, P., Rodari, G., Giavoli, C., & Lania, A. (2017). Central hypothyroidism—A neglected thyroid disorder. Nature Reviews. Endocrinology, 13(10), 588–598. https://doi.org/10.1038/nrendo.2017.47

Celi, F. S., Zemskova, M., Linderman, J. D., Babar, N. I., Skarulis, M. C., Csako, G., Wesley, R., Costello, R., Penzak, S. R., & Pucino, F. (2010). The pharmacodynamic equivalence of levothyroxine and liothyronine. A randomized, double blind, cross-over study in thyroidectomized patients. Clinical Endocrinology, 72(5), 709–715. https://doi.org/10.1111/j.1365-2265.2009.03700.x

Celi, F. S., Zemskova, M., Linderman, J. D., Smith, S., Drinkard, B., Sachdev, V., Skarulis, M. C., Kozlosky, M., Csako, G., Costello, R., & Pucino, F. (2011). Metabolic effects of liothyronine therapy in hypothyroidism: A randomized, double-blind, crossover trial of liothyronine versus levothyroxine. The Journal of Clinical Endocrinology and Metabolism, 96(11), 3466–3474. https://doi.org/10.1210/jc.2011-1329

Davis, P. J., Leonard, J. L., Lin, H.-Y., Leinung, M., & Mousa, S. A. (2018). Molecular Basis of Nongenomic Actions of Thyroid Hormone. Vitamins and Hormones, 106, 67–96. https://doi.org/10.1016/bs.vh.2017.06.001

Dumitrescu, A. M., Di Cosmo, C., Liao, X.-H., Weiss, R. E., & Refetoff, S. (2010). The syndrome of inherited partial SBP2 deficiency in humans. Antioxidants & Redox Signaling, 12(7), 905–920. https://doi.org/10.1089/ars.2009.2892

Escobar-Morreale, H. F., Botella-Carretero, J. I., Gómez-Bueno, M., Galán, J. M., Barrios, V., & Sancho, J. (2005). Thyroid hormone replacement therapy in primary hypothyroidism: A randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Annals of Internal Medicine, 142(6), 412–424.

Watanabe, M., Iwatani, Y., Kashiwai, T., Iijima, T., Fujikado, T., & Amino, N. (1995). Euthyroid Graves’ disease showing no thyroid abnormalities except positive thyroid-stimulating antibody (TSAb): Two case reports. Journal of Internal Medicine, 238(4), 379–384. https://doi.org/10.1111/j.1365-2796.1995.tb01214.x

Galton, V. A., Schneider, M. J., Clark, A. S., & St. Germain, D. L. (2009). Life without Thyroxine to 3,5,3′-Triiodothyronine Conversion: Studies in Mice Devoid of the 5′-Deiodinases. Endocrinology, 150(6), 2957–2963. https://doi.org/10.1210/en.2008-1572

Groeneweg, S., Peeters, R. P., Visser, T. J., & Visser, W. E. (2017). Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes. Molecular and Cellular Endocrinology, 458, 82–90. https://doi.org/10.1016/j.mce.2017.02.029

Hoermann, R., Larisch, R., Dietrich, J. W., & Midgley, J. E. M. (2016a). Derivation of a multivariate reference range for pituitary thyrotropin and thyroid hormones: Diagnostic efficiency compared with conventional single-reference method. European Journal of Endocrinology, 174(6), 735–743. https://doi.org/10.1530/EJE-16-0031

Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2016b). Relational Stability of Thyroid Hormones in Euthyroid Subjects and Patients with Autoimmune Thyroid Disease. European Thyroid Journal, 5(3), 171–179. https://doi.org/10.1159/000447967

Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019). Functional and Symptomatic Individuality in the Response to Levothyroxine Treatment. Frontiers in Endocrinology, 10. https://doi.org/10.3389/fendo.2019.00664

Hoermann, R., Pekker, M. J., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2020). Triiodothyronine secretion in early thyroid failure: The adaptive response of central feedforward control. European Journal of Clinical Investigation, 50(2), e13192. https://doi.org/10.1111/eci.13192

Ito, M., Miyauchi, A., Hisakado, M., Yoshioka, W., Ide, A., Kudo, T., Nishihara, E., Kihara, M., Ito, Y., Kobayashi, K., Miya, A., Fukata, S., Nishikawa, M., Nakamura, H., & Amino, N. (2017). Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy. Thyroid, 27(4), 484–490. https://doi.org/10.1089/thy.2016.0426

Larisch, R., Midgley, J. E. M., Dietrich, J. W., & Hoermann, R. (2018). Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 126(9), 546–552. https://doi.org/10.1055/s-0043-125064

Lin, H.-Y., Tang, H.-Y., Leinung, M., Mousa, S. A., Hercbergs, A., & Davis, P. J. (2019). Action of Reverse T3 on Cancer Cells. Endocrine Research, 1–5. https://doi.org/10.1080/07435800.2019.1600536

Meier, C., Trittibach, P., Guglielmetti, M., Staub, J.-J., & Müller, B. (2003). Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: Cross sectional survey. BMJ, 326(7384), 311–312. https://doi.org/10.1136/bmj.326.7384.311

Midgley, J. E. M., Larisch, R., Dietrich, J. W., & Hoermann, R. (2015). Variation in the biochemical response to l-thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency. Endocrine Connections, 4(4), 196–205. https://doi.org/10.1530/EC-15-0056

Monaco, F. (2003). Classification of Thyroid Diseases: Suggestions for a Revision. The Journal of Clinical Endocrinology & Metabolism, 88(4), 1428–1432. https://doi.org/10.1210/jc.2002-021260

Pilo, A., Iervasi, G., Vitek, F., Ferdeghini, M., Cazzuola, F., & Bianchi, R. (1990). Thyroidal and peripheral production of 3,5,3’-triiodothyronine in humans by multicompartmental analysis. The American Journal of Physiology, 258(4 Pt 1), E715-726. https://doi.org/10.1152/ajpendo.1990.258.4.E715

Sesmilo, G., Simó, O., Choque, L., & Casamitjana, R. (2011). Serum free triiodothyronine (T3) to free thyroxine (T4) ratio in treated central hypothyroidism compared with primary hypothyroidism and euthyroidism. Endocrinología y Nutrición (English Edition), 58(1), 9–15. https://doi.org/10.1016/S2173-5093(11)70031-9

Takasu, N., & Matsushita, M. (2012). Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves’ Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients. Journal of Thyroid Research, 2012, 182176. https://doi.org/10.1155/2012/182176

Yavuz, S., Linderman, J. D., Smith, S., Zhao, X., Pucino, F., & Celi, F. S. (2013). The Dynamic Pituitary Response to Escalating-Dose TRH Stimulation Test in Hypothyroid Patients Treated With Liothyronine or Levothyroxine Replacement Therapy. The Journal of Clinical Endocrinology & Metabolism, 98(5), E862–E866. https://doi.org/10.1210/jc.2012-4196

Back to article on Page 1


Pages: 1 2


Categories: Therapy paradigms, Thyroid hormone effects

4 replies

Trackbacks

  1. The Spectrum of Thyroid Autoimmunity – Thyroid Patients Canada
  2. Normal FT3:FT4 thyroid hormone ratios in large populations – Thyroid Patients Canada
  3. Remissions and fluctuations in autoimmune thyroid disease: TRAb – Thyroid Patients Canada
  4. Focusing on T3: The T3 hormone or the LT3 pharmaceutical? – Thyroid Patients Canada

Leave a public reply here, on our website.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: